Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 4CNS 4Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Lung Neoplasms 6Breast Neoplasms 5Prostatic Neoplasms 3Melanoma 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Liver Neoplasms 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Sarcoma 1Pheochromocytoma 1Paraganglioma, Extra-Adrenal 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasms 1Mesothelioma 1Head and Neck Neoplasms 1Glioblastoma 1Extensive Stage Small Cell Lung Cancer 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

entinostat 1cediranib 1carboxyamido-triazole 1Thalidomide 1Tamoxifen 1Sirolimus 1Radiotherapy 1Paclitaxel 1Immunologic Techniques 1Fentanyl 1Erlotinib Hydrochloride 1Doxorubicin 1Docetaxel 1Cisplatin 190Y-octreotide, DOTA-Tyr(3)- 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oligodendroglioma × Sirolimus × Thoracic × Clear all
NCT01522820 2016-10-04

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Roswell Park Cancer Institute

Phase 1 Completed
18 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Astrocytoma, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Oligodendroglioma, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡